Recruiting Melanoma Studies in Omaha
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
This clinical trial is a prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase 3 clinical trial to evaluate the efficacy, safety and tolerability of treatment wit...
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluate...
About Melanoma Clinical Trials in Omaha
Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. While less common than other skin cancers, melanoma is more likely to spread. Immunotherapy and targeted therapy have revolutionized melanoma treatment.
There are currently 2 melanoma clinical trials recruiting participants in Omaha, NE. These studies are seeking a combined 624 participants. Research is being sponsored by Immatics US, Inc., Perspective Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Melanoma Clinical Trials in Omaha — FAQ
Are there melanoma clinical trials in Omaha?
Yes, there are 2 melanoma clinical trials currently recruiting in Omaha, NE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Omaha?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.
Are clinical trials in Omaha free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.
What melanoma treatments are being tested?
The 2 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for melanoma.
Data updated March 2, 2026 from ClinicalTrials.gov